🇺🇸 FDA
Patent

US 7547698

Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)

granted A61KA61K31/497A61K31/50

Quick answer

US patent 7547698 (Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)) held by Xenon Pharmaceuticals Inc. expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/497, A61K31/50, A61P, A61P1/16